Thiazolidinediones double fracture risk in women with type 2 diabetes
Clinicians are advised to reconsider the use of thiazolidinediones in women with type 2 diabetes following research showing that long-term use doubles the risk of fracture in this population....
Want to read complete article? Please Sign in or Register.